Clinical Trial Update: A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating contraceptive efficacy and safety of the etonogestrel subdermal implant Implanon® (P06473) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Implanon (etonogestrel implant)

Snippet

Sponsor: Organon and Co | Conditions: Contraception | Phase 4 | Status: COMPLETED